Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ · Healthcare
Whitehawk Therapeutics, Inc. Shareholder Equity 2018–2025
Whitehawk Therapeutics, Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Whitehawk Therapeutics, Inc. shareholder equity as of December 31, 2025: 136.3M, a 159.75% increase year-over-year.
- Whitehawk Therapeutics, Inc. shareholder equity for 2025 were 136.3M, a 159.75% increase from 2024.
- Whitehawk Therapeutics, Inc. shareholder equity for 2024 were 52.5M, a 50.11% decrease from 2023.
- Whitehawk Therapeutics, Inc. shareholder equity for 2023 were 105.2M, a 33.58% decrease from 2022.
- Whitehawk Therapeutics, Inc. shareholder equity for 2022 were 158.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Whitehawk Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $136 |
| 2024 | $52 |
| 2023 | $105 |
| 2022 | $158 |
| 2021 | $136 |
| 2020 | $-12 |
| 2019 | $-9 |
| 2018 | $59 |
Whitehawk Therapeutics, Inc. Shareholder Equity — FAQ
Whitehawk Therapeutics, Inc. (WHWK) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WHWK's shareholder equity history?
The chart and table above show Whitehawk Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.